Murano Trial Establishes Feasibility Of Time-Limited Venetoclax-Rituximab (Venr) Combination Therapy In Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (Cll)
John F. Seymour,Thomas J. Kipps,Barbara Eichhorst,Peter Hillmen,James D'Rozario,Sarit Assouline,Carolyn Owen,Tadeusz Robak,Javier de la Serna,Ulrich Jaeger,Guillaume Cartron,Marco Montillo,Nicole Lamanna,Maria E. Verdugo,Elizabeth A Punnoose,Yanwen Jiang,Jue Wang,Michelle Boyer,Kathryn Humphrey,Mehrdad Mobasher,Arnon P. Kater BLOOD（2018）
AI 理解论文
溯源树
样例
